[HOME] > News & Events > News
News   June 30, 2007 ARC Pharmaceuticals Announces that Preclinical Efficacy Data Related to its Lead Product Candidate Were Presented at ECVS 2007 May 3, 2007 ARC Pharmaceuticals Announces that Key Patents Related to its Lead Product Candidate Were Recently Issued in Several Territories June 24, 2005 ARC Pharmaceuticals Inc. Presents Data at the 21st Annual Meeting of the European Society of Human Reproduction and Embryology April 28, 2005 ARC Pharmaceuticals Selected to Present at Invest Northwest 2005 March 29, 2005 ARC Pharmaceuticals invited to present at Convergence: The Drug/Device Summit in Pittsburgh, PA November 17, 2004 ARC selected as one of Canada's Top 10 life sciences investment and partnership prospects for 2004. October 25, 2004 ARC Pharmaceuticals Inc. Presents Results at the American Society for Reproductive Medicine Annual Meeting September 28, 2004 ARC Pharmaceuticals Inc. Raises CDN $1.6 Million September 9, 2004 Dr. Johanne Cashman, ARC Pharmaceuticals Inc., Publishes Paper in Inflammation Research Describing Novel Treatment for Preventio March 25, 2004 ARC Pharmaceuticals Invited to Present at the 6th Annual Southern California BioMedical Council Investor Conference March 15, 2004 ARC Pharmaceuticals Selected to Present at Invest Northwest 2004 November 18, 2003 ARC Pharmaceuticals and The University of British Columbia Sign Exclusive License Agreement. October 9, 2003 ARC selected as one of Canada's Top 10 life sciences investment and partnership prospects for 2003. September 18, 2003 ARC featured in an article entitled "Getting There - Discovering and optimizing drug delivery in Canada" in Biotechnology Focus. August 11, 2003 ARC Pharmaceuticals Inc. Presents Data at the 6th World Congress on Inflammation in Vancouver, British Columbia May 28, 2003 ARC Pharmaceuticals receives Eligible Business Corporation (EBC) Status May 16, 2003 ARC Pharmaceuticals invited to present at BioFinance, Toronto, Ontario May 12, 2003 Dr. John North Joins ARC Pharmaceuticals' Board of Directors March 12, 2003 ARC Pharmaceuticals invited to present at Invest Northwest, Seattle, Washington February 11, 2003 ARC Pharmaceuticals invited to present at Antisense and SiRNA Technologies Conference in London October 31, 2002 ARC Pharmaceuticals and The University of British Columbia Sign License Agreement September 24, 2002 ARC Pharmaceuticals Receives Cdn $225,295 Research Award From the Industrial Research Assistance Program September 18, 2002 ARC Pharmaceuticals Inc. Appoints Chief Financial Officer and Strengthens Board of Directors August 12, 2002 ARC Pharmaceuticals Inc. Signs Research and Option Agreement with McGill University June 21, 2002 ARC Pharmaceuticals Appoints Michael Diamond, MD and Victor Gomel, MD to its Scientific Advisory Board March 25, 2002 ARC Pharmaceuticals Inc. Completes Seed Financing
Home   •   Corporate   •   Research & Development   •   People   •   News & Events   •   Contact Us
© 2003 - 2008 ARC Pharmaceuticals Inc.